Yang Dae Yul, Jeong Hyun Cheol, Ko Kyungtae, Lee Seong Ho, Lee Young Goo, Lee Won Ki
Department of Urology, College of Medicine, Hallym Unversity, Kangdong Sacred Heart Hospital, Seoul 05355, Korea.
Department of Urology, College of Medicine, Hallym Unversity, Dongtan Sacred Heart Hospital, Hwaseong 18450, Korea.
J Clin Med. 2020 Apr 5;9(4):1024. doi: 10.3390/jcm9041024.
Although several types of penile augmentation (PA) fillers have been recently introduced, no long-term follow-up studies have compared them. This study aimed to compare the long-term clinical outcomes of hyaluronic acid (HA) and polylactic acid (PLA) filler injections for PA. Our multicenter, patient-blinded/evaluator-blinded, randomized comparative trial was performed for 18 months after the single injection of fillers. Sixty-seven healthy men reporting a small penis were administered an injection between November 2016 and May 2017. Subjects were divided into the HA group (n = 33) and PLA group (n = 34). At 18 months, the mean penile girths had significantly increased in both groups (each < 0.001). Changes in the mean penile girth of both groups were not significantly different during the study period. Satisfaction levels at 18 months were significantly higher than those at baseline in both groups (each < 0.01). Changes in satisfaction levels did not differ significantly during the study period. Injection-associated adverse events (AEs) occurred in three (9.1%) patients in the HA group and in two (5.9%) patients in the PLA group; no serious AEs occurred. In conclusion, HA and PLA filler injections for PA led to significant augmentation and increased satisfaction. Clinical efficacy and safety were comparable between groups.
尽管最近已推出几种类型的阴茎增大(PA)填充剂,但尚无长期随访研究对它们进行比较。本研究旨在比较透明质酸(HA)和聚乳酸(PLA)填充剂注射用于PA的长期临床效果。我们的多中心、患者盲法/评估者盲法随机对照试验在单次注射填充剂后进行了18个月。2016年11月至2017年5月期间,对67名自述阴茎短小的健康男性进行了注射。受试者分为HA组(n = 33)和PLA组(n = 34)。18个月时,两组的平均阴茎周长均显著增加(均P < 0.001)。在研究期间,两组平均阴茎周长的变化无显著差异。两组18个月时的满意度均显著高于基线时(均P < 0.01)。在研究期间,满意度的变化无显著差异。HA组有3例(9.1%)患者发生注射相关不良事件(AE),PLA组有2例(5.9%)患者发生;无严重AE发生。总之,HA和PLA填充剂注射用于PA可导致显著增大并提高满意度。两组间临床疗效和安全性相当。